MariMed Inc. (OTCMKTS:MRMD – Get Free Report) was the recipient of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 57,300 shares, a drop of 63.1% from the February 28th total of 155,100 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average trading volume of 723,400 shares, the short-interest ratio is currently 0.1 days.
MariMed Price Performance
MRMD stock traded down $0.00 during mid-day trading on Friday, reaching $0.10. 184,179 shares of the company traded hands, compared to its average volume of 376,969. The company has a fifty day moving average price of $0.12 and a 200-day moving average price of $0.14. MariMed has a 52-week low of $0.09 and a 52-week high of $0.34. The company has a market capitalization of $36.93 million, a P/E ratio of -2.42 and a beta of 2.70. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.55 and a quick ratio of 0.73.
MariMed (OTCMKTS:MRMD – Get Free Report) last posted its earnings results on Wednesday, March 5th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01). The business had revenue of $39.00 million for the quarter, compared to analysts’ expectations of $42.00 million. MariMed had a negative net margin of 10.97% and a negative return on equity of 2.75%.
MariMed Company Profile
MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand.
Further Reading
- Five stocks we like better than MariMed
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- MarketBeat Week in Review – 03/24 – 03/28
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Dividend Capture Strategy: What You Need to Know
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.